Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eric Kohler

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 26, 2025
Rational redesign of antigen binding domain improves in vivo efficacy of the CD22-CARKole R DeGolier, Catherine Pham-Danis, Samuel D Burciaga, et al.
Nature Communications|May 24, 2024
Deleting the mitochondrial respiration negative regulator MCJ enhances the efficacy of CD8<sup>+</sup> T cell adoptive therapies in pre-clinical studiesMeng-Han Wu, Felipe Valenca-Pereira, Francesca Cendali, et al.
Nature Medicine|May 5, 2015
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsAdrienne H Long, Waleed M Haso, Jack F Shern, et al.
The Journal of Clinical Investigation|September 14, 2020
Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patientsKazusa Ishii, Marie Pouzolles, Christopher D Chien, et al.
Leukemia|July 1, 2026
FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemiaClarissa Garcia, Kaylyn U Lyons, Julian Grandvallet Contreras, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 26, 2025
Rational redesign of antigen binding domain improves in vivo efficacy of the CD22-CARKole R DeGolier, Catherine Pham-Danis, Samuel D Burciaga, et al.
Nature Communications|May 24, 2024
Deleting the mitochondrial respiration negative regulator MCJ enhances the efficacy of CD8<sup>+</sup> T cell adoptive therapies in pre-clinical studiesMeng-Han Wu, Felipe Valenca-Pereira, Francesca Cendali, et al.
Nature Medicine|May 5, 2015
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsAdrienne H Long, Waleed M Haso, Jack F Shern, et al.
The Journal of Clinical Investigation|September 14, 2020
Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patientsKazusa Ishii, Marie Pouzolles, Christopher D Chien, et al.
Leukemia|July 1, 2026
FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemiaClarissa Garcia, Kaylyn U Lyons, Julian Grandvallet Contreras, et al.
Pageof 3